Bei Zheng

发表

A Study to Decipher the Potential Effects of Butylphthalide against Central Nervous System Diseases Based on Network Pharmacology and Molecular Docking Integration Strategy

Qinqin Zhao, Xiang Li, P. Feng, 2021, Evidence-based complementary and alternative medicine : eCAM.

AStudy toDecipher thePotential Effects ofButylphthalide against CentralNervousSystemDiseasesBasedonNetworkPharmacology and Molecular Docking Integration Strategy

Qinqin Zhao, Xiang Li, P. Feng, 2021 .

A Meta-Analysis of Abnormal Glucose Metabolism in First-Episode Drug-Naive Schizophrenia.

Jun Zhu, Wenjuan Yang, Bingqing Liang, 2020, Psychiatria Danubina.

Insights Into the Resistance Mechanisms of Inhibitors to FLT3 F691L Mutation via an Integrated Computational Approach

Qinqin Zhao, Y. Ying, Meiling Zhang, 2019, Front. Pharmacol..

A Bayesian network meta‐analysis of ALK inhibitor treatments in patients with ALK‐positive non‐small cell lung cancer

Miao Chen, Wenjuan Yang, Bingqing Liang, 2023, Cancer medicine.

Antiviral Treatment in Older Chinese Patient with SARS-CoV-2 and Influenza A Virus Co-Infection: A Case Series

Wenjuan Yang, Meiling Zhang, Gonghua Li, 2023, Infection and drug resistance.

Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study

Qinqin Zhao, Y. Ying, Hongxun Jiang, 2023, Infectious Diseases and Therapy.

Case report: ATM A1159T mutation in malignant peritoneal mesothelioma may be associated with tumor recurrence

Na Yan, Bei Zheng, Ying Li, 2024, SAGE open medical case reports.

Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China

Xueshan Sun, Zixuan Zhao, Bei Zheng, 2024, Clinical Medicine Insights. Oncology.

Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review

Bei Zheng, Wenjuan Yang, Meiling Zhang, 2024, BMC psychiatry.